Insights into Gene Therapy Manufacturing and Preclinical Data Revealed.

Tessera Therapeutics, a biotech startup developing gene editing tools, has revealed preliminary data from five preclinical programs using its "gene writers" to treat genetic diseases. Meanwhile, Comanche Biopharma, a new siRNA biotech, is nearing clinical trials for a one-time therapy to treat preeclampsia. The Supreme Court has ruled in favor of Sanofi and Regeneron in a patent battle with Amgen, and an FDA panel has backed Pfizer's RSV vaccine. Catalent has announced drastic measures to right its business, and Moderna has presented early data on its mRNA treatment for propionic acidemia.